BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 12693761)

  • 1. Growth hormone: beyond therapeutic prescription--a magic fountain of youth?
    Rajasoorya C
    Singapore Med J; 2002 Dec; 43(12):601-4. PubMed ID: 12693761
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of human pituitary growth hormone on body composition.
    van der Werff ten Bosch JJ; Bot A
    Neth J Med; 1987 Jun; 30(5-6):220-7. PubMed ID: 3627306
    [No Abstract]   [Full Text] [Related]  

  • 3. [Growth hormone treatment of short children born small for gestational age].
    Christesen HB; Jensen RB; Birkebaek NH; Hertel NT; Main KM; Mortensen HB; Naeraa RW; Juul A
    Ugeskr Laeger; 2006 Feb; 168(9):889-95. PubMed ID: 16513050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aging and fountain-of-youth hormones.
    Stewart PM
    N Engl J Med; 2006 Oct; 355(16):1724-6. PubMed ID: 17050897
    [No Abstract]   [Full Text] [Related]  

  • 5. Randomized controlled GH trial: effects on anthropometry, body composition and body proportions in a large group of children with Prader-Willi syndrome.
    Festen DA; de Lind van Wijngaarden R; van Eekelen M; Otten BJ; Wit JM; Duivenvoorden HJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):443-51. PubMed ID: 18363884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How effective and safe is growth hormone therapy in children born small for gestational age?
    J Pediatr Endocrinol Metab; 2004 Feb; 17 Suppl 2():263-6. PubMed ID: 15116949
    [No Abstract]   [Full Text] [Related]  

  • 7. [Growth hormone treatment of small children with normal growth hormone secretion].
    Kruse K
    Monatsschr Kinderheilkd; 1993 May; 141(5):438. PubMed ID: 8326967
    [No Abstract]   [Full Text] [Related]  

  • 8. Growth hormone treatment completely normalizes adult height and improves body composition in Prader-Willi syndrome: experience from KIGS (Pfizer International Growth Database).
    Lindgren AC; Lindberg A
    Horm Res; 2008; 70(3):182-7. PubMed ID: 18663319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical indicators of biochemical remission in acromegaly: does incomplete disease control always mean therapeutic failure?
    Damjanovic SS; Neskovic AN; Petakov MS; Popovic V; Macut D; Vukojevic P; Joksimovic MM
    Clin Endocrinol (Oxf); 2005 Apr; 62(4):410-7. PubMed ID: 15807870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effects of growth hormone (GH) treatment on body composition and bone mineral density in short children born small-for-gestational-age: six-year follow-up of a randomized controlled GH trial.
    Willemsen RH; Arends NJ; Bakker-van Waarde WM; Jansen M; van Mil EG; Mulder J; Odink RJ; Reeser M; Rongen-Westerlaken C; Stokvis-Brantsma WH; Waelkens JJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):485-92. PubMed ID: 17561977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
    Högler W; Briody J; Moore B; Lu PW; Cowell CT
    Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment with growth hormone is not a luxury].
    Albertsson-Wikland K
    Lakartidningen; 1994 Apr; 91(17):1691. PubMed ID: 8189899
    [No Abstract]   [Full Text] [Related]  

  • 13. Growth hormone replacement in adults: what dose?
    Ross RJ
    Clin Endocrinol (Oxf); 1993 Oct; 39(4):401-2. PubMed ID: 8287566
    [No Abstract]   [Full Text] [Related]  

  • 14. Growth shots for Jr.
    Gupta S
    Time; 2003 Aug; 162(8):69. PubMed ID: 12964465
    [No Abstract]   [Full Text] [Related]  

  • 15. The impact of idiopathic childhood-onset growth hormone deficiency (GHD) on bone mass in subjects without adult GHD.
    Lange M; Müller J; Svendsen OL; Kastrup KW; Juul A; Feldt-Rasmussen U
    Clin Endocrinol (Oxf); 2005 Jan; 62(1):18-23. PubMed ID: 15638865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human growth hormone: the Fountain of Youth?
    Walker C
    Geriatrics; 1990 Oct; 45(10):18-9. PubMed ID: 2210390
    [No Abstract]   [Full Text] [Related]  

  • 17. Somatic characteristics and cardiovascular risk factors in growth hormone deficiency: a randomized, double-blind, placebo-controlled study of the effect of treatment with recombinant human growth hormone.
    Bell W; Davies JS; Evans WD; Scanlon MF; Mullen R
    Am J Hum Biol; 2004; 16(5):533-43. PubMed ID: 15368601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Can growth hormone therapy delay normal aging?].
    Thorén M; Hall K
    Lakartidningen; 1991 May; 88(21):1953-4. PubMed ID: 2056808
    [No Abstract]   [Full Text] [Related]  

  • 19. Growth hormone treatment for idiopathic short stature: implications for practice and policy.
    Cuttler L; Silvers JB
    Arch Pediatr Adolesc Med; 2004 Feb; 158(2):108-10. PubMed ID: 14757600
    [No Abstract]   [Full Text] [Related]  

  • 20. A randomized, double-blind study to assess the efficacy and safety of valtropin, a biosimilar growth hormone, in children with growth hormone deficiency.
    Peterkova V; Arslanoglu I; Bolshova-Zubkovskaya E; Romer T; Zdravkovic D; Kratzsch J; Ji HJ; Savoy C; Saenger P
    Horm Res; 2007; 68(6):288-93. PubMed ID: 17627092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.